China Jo-Jo Drugstores, Inc. ('Jo-Jo Drugstores' or the 'Company'), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies.
Company profile
Ticker
CJJD
Exchange
Website
CEO
Lei Liu
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
KERRISDALE MINING CORP
SEC CIK
Corporate docs
Subsidiaries
Of China Jo-Jo Drugstores, Inc. • Renovation Investment (Hong Kong) Co., Ltd. • Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. • Hangzhou Shouantang Bio-technology Co., Ltd. • Hangzhou Kahamadi Bio-technology Co. • Hangzhou Jiuyi Medical Technology Co. Ltd. • Zhejiang Jiuxin Investment Management Co., Ltd. • Hangzhou Qianhong Agriculture Development Co., Ltd. • Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. • Zhejiang Jiuxin Medicine Co., Ltd. ...
IRS number
980557582
CJJD stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
30 Jul 21
25-NSE
Exchange delisting
29 Jul 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
20 Jul 21
8-K
China Jo-Jo Drugstores Reports Fiscal Year 2021 Financial Results
1 Jul 21
10-K
2021 FY
Annual report
29 Jun 21
DEF 14A
Definitive proxy
2 Jun 21
8-K
Entry into a Material Definitive Agreement
14 May 21
8-K
Amendments to Articles of Incorporation or Bylaws
22 Apr 21
8-K
China Jo-Jo Drugstores Reports Third Quarter Fiscal 2021 Financial Results
12 Feb 21
Latest ownership filings
Financial summary
Quarter (USD) | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 34.67 mm | 34.67 mm | 34.67 mm | 34.67 mm | 34.67 mm | 34.67 mm |
Cash burn (monthly) | (no burn) | (no burn) | 177.64 k | 738.26 k | (no burn) | 5.19 k |
Cash used (since last report) | n/a | n/a | 6.55 mm | 27.21 mm | n/a | 191.34 k |
Cash remaining | n/a | n/a | 28.12 mm | 7.46 mm | n/a | 34.48 mm |
Runway (months of cash) | n/a | n/a | 158.3 | 10.1 | n/a | 6642.5 |
Institutional ownership, Q4 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|